APA (7th ed.) Citation

Gallagher, L., Cregan, S., Biniecka, M., Cunningham, C., Veale, D. J., Kane, D. J., . . . Mullan, R. H. (2020). Insulin‐Resistant Pathways Are Associated With Disease Activity in Rheumatoid Arthritis and Are Subject to Disease Modification Through Metabolic Reprogramming: A Potential Novel Therapeutic Approach. Arthritis & rheumatology (Hoboken, N.J.), 72(6), 896-902. https://doi.org/10.1002/art.41190

Chicago Style (17th ed.) Citation

Gallagher, Lorna, Sian Cregan, Monika Biniecka, Clare Cunningham, Douglas J. Veale, David J. Kane, Ursula Fearon, and Ronan H. Mullan. "Insulin‐Resistant Pathways Are Associated With Disease Activity in Rheumatoid Arthritis and Are Subject to Disease Modification Through Metabolic Reprogramming: A Potential Novel Therapeutic Approach." Arthritis & Rheumatology (Hoboken, N.J.) 72, no. 6 (2020): 896-902. https://doi.org/10.1002/art.41190.

MLA (9th ed.) Citation

Gallagher, Lorna, et al. "Insulin‐Resistant Pathways Are Associated With Disease Activity in Rheumatoid Arthritis and Are Subject to Disease Modification Through Metabolic Reprogramming: A Potential Novel Therapeutic Approach." Arthritis & Rheumatology (Hoboken, N.J.), vol. 72, no. 6, 2020, pp. 896-902, https://doi.org/10.1002/art.41190.